X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1917) 1917
male (1183) 1183
female (1142) 1142
intracranial hemorrhages - chemically induced (865) 865
aged (858) 858
middle aged (798) 798
anticoagulants - adverse effects (648) 648
clinical neurology (639) 639
stroke (533) 533
risk factors (531) 531
adult (499) 499
intracranial hemorrhage (491) 491
treatment outcome (448) 448
aged, 80 and over (427) 427
warfarin (379) 379
peripheral vascular disease (371) 371
hemorrhage (367) 367
cerebral hemorrhage - chemically induced (352) 352
retrospective studies (326) 326
fibrinolytic agents - adverse effects (304) 304
warfarin - adverse effects (303) 303
hemorrhage - chemically induced (294) 294
risk (282) 282
anticoagulants - therapeutic use (278) 278
anticoagulants (275) 275
therapy (274) 274
intracerebral hemorrhage (269) 269
neurosciences (260) 260
time factors (258) 258
stroke - drug therapy (251) 251
surgery (250) 250
animals (245) 245
neurology (243) 243
tissue plasminogen activator - adverse effects (233) 233
anticoagulants - administration & dosage (230) 230
management (226) 226
thrombolytic therapy - adverse effects (214) 214
tomography, x-ray computed (212) 212
mortality (211) 211
atrial fibrillation - drug therapy (192) 192
stroke - prevention & control (192) 192
risk assessment (190) 190
medicine, general & internal (189) 189
atrial fibrillation (186) 186
cardiac & cardiovascular systems (182) 182
abridged index medicus (178) 178
platelet aggregation inhibitors - adverse effects (177) 177
administration, oral (174) 174
stroke - etiology (170) 170
medicine & public health (169) 169
brain (168) 168
brain ischemia - drug therapy (168) 168
care and treatment (159) 159
atrial fibrillation - complications (158) 158
thrombolysis (157) 157
hematology (156) 156
fibrinolytic agents - administration & dosage (154) 154
atrial-fibrillation (152) 152
fibrinolytic agents - therapeutic use (151) 151
intracranial hemorrhages - epidemiology (147) 147
anticoagulation (145) 145
aspirin (145) 145
dabigatran (142) 142
tissue plasminogen activator - administration & dosage (141) 141
international normalized ratio (140) 140
prospective studies (132) 132
prevention (131) 131
subarachnoid hemorrhage (131) 131
adolescent (128) 128
analysis (123) 123
safety (123) 123
warfarin - therapeutic use (122) 122
ischemia (121) 121
thrombolytic therapy (121) 121
acute ischemic-stroke (113) 113
incidence (113) 113
magnetic resonance imaging (111) 111
tissue plasminogen activator - therapeutic use (109) 109
aspirin - adverse effects (107) 107
cohort studies (105) 105
tissue-plasminogen activator (104) 104
critical care medicine (101) 101
follow-up studies (101) 101
drug therapy (100) 100
health aspects (100) 100
bleeding (99) 99
complications (99) 99
dose-response relationship, drug (99) 99
thromboembolism (99) 99
complications and side effects (98) 98
thrombosis (98) 98
tissue plasminogen activator (98) 98
cardiovascular (96) 96
age factors (95) 95
gastrointestinal hemorrhage - chemically induced (95) 95
platelet aggregation inhibitors - therapeutic use (95) 95
cerebral angiography (94) 94
drug therapy, combination (94) 94
rivaroxaban (94) 94
disease models, animal (93) 93
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1982) 1982
German (38) 38
French (30) 30
Japanese (25) 25
Spanish (23) 23
Russian (9) 9
Turkish (5) 5
Danish (4) 4
Chinese (3) 3
Hungarian (3) 3
Italian (3) 3
Swedish (3) 3
Dutch (2) 2
Polish (2) 2
Portuguese (2) 2
Bulgarian (1) 1
Czech (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 12, pp. 1131 - 1141
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 1, pp. 9 - 19
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 14, pp. 1326 - 1335
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 15, pp. 1404 - 1413
.... After 2 years, the data and safety monitoring board recommended discontinuation of the study treatment in patients with a history of stroke owing to the risk of intracranial hemorrhage. RESULTS... 
ATOPAXAR | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | EFFICACY | SAFETY | TOLERABILITY | DOUBLE-BLIND | PRASUGREL | LESSONS | ANTAGONISTS | ASPIRIN | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Computer Science | Medical Imaging
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 5, pp. 431 - 441
Journal Article